Thursday, June 18, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Energy & Oil

RWE’s Welsh Solar Setback Fails to Dampen Record Share Price Momentum

Jackson Burston by Jackson Burston
April 27, 2026
in Energy & Oil, European Markets, Renewable Energy
0
Rwe Stock
0
SHARES
26
VIEWS
Share on FacebookShare on Twitter

RWE’s stock touched a fresh 52-week high of €60.86 on Wednesday, even as the German utility grapples with regulatory headwinds in Britain and quietly shelves a major solar project in Wales. The 99.9 MW “Butterfly” solar development has been scrapped after grid connection proved unfeasible, underscoring the infrastructure bottlenecks that continue to plague the UK’s energy transition.

The cancellation comes as RWE navigates a broader debate over London’s electricity market reforms. Proposals to decouple gas and electricity prices have weighed on sentiment across the sector, with Jefferies estimating that a roughly £5 per megawatt-hour price shift could shave 2-3% off net profits for affected generators — including RWE, SSE, Centrica and Ørsted. Bernstein Research, however, has pushed back against the bearish narrative, arguing the market’s reaction looks overdone. While the reforms may cap upside, the analyst sees no material downside risk.

Yet for every setback in Britain, RWE appears to have a compensating victory elsewhere. The company emerged as the biggest winner in the UK’s seventh Contracts for Difference auction, securing 6.9 GW of offshore wind capacity from a record 8.4 GW allocation. The projects — Norfolk Vanguard East and West, two Dogger Bank South developments, and Awel y Môr — carry a strike price of £91.20/MWh. Final investment decisions on the Vanguard projects are expected by summer 2026, with Vanguard West slated for commissioning in 2029 and Vanguard East a year later.

UBS responded by lifting its price target on RWE from €55 to €65, maintaining a “Buy” rating. The analyst trimmed the 2026 EBITDA forecast by 3% but raised estimates for 2028-2030 by as much as 8% to reflect the new capacity. Barclays also remains bullish, keeping an “Overweight” rating with a €66 target. Analyst Peter Crampton expects Germany’s Kraftwerksstrategie — a 12 GW tender for hydrogen-ready power plants — to be unveiled by the end of the second quarter. RWE CEO Markus Krebber has publicly stated the company aims to secure up to 3 GW in the initial rounds.

Should investors sell immediately? Or is it worth buying Rwe?

The share buyback programme continues to provide a floor for the stock. During the week of March 30 to April 2, RWE repurchased nearly 290,000 shares on Xetra, while the following week saw 357,000 shares bought back. Since the third tranche launched in December 2025, the company has accumulated over 7.3 million shares. The €1.5 billion programme runs until June 2026.

Management has held firm on its full-year guidance, targeting adjusted operating earnings of up to €5.8 billion for 2026. The broader investment plan — €35 billion through 2031 — remains intact, with grid subsidiary Amprion alone spending a record €7.3 billion this year. A strategic focus on US gas-fired power plants, designed to backstop energy-intensive AI data centres, adds another growth vector.

The next major catalyst arrives on May 13, when RWE publishes its first-quarter results. Investors will be watching for signs that US projects are ramping without significant cost overruns — a key test for the company’s ambitious growth trajectory. Before that, the virtual annual general meeting on April 30 will put the 2025 dividend to a shareholder vote, with plans to raise the payout to €1.32 per share for 2026, targeting 10% annual growth.

Since the start of the year, RWE shares have gained nearly 30%. The May quarterly report will need to validate that rally with operational substance.

Ad

Rwe Stock: Buy or Sell?! New Rwe Analysis from June 18 delivers the answer:

The latest Rwe figures speak for themselves: Urgent action needed for Rwe investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 18.

Rwe: Buy or sell? Read more here...

Tags: Rwe
Jackson Burston

Jackson Burston

Related Posts

D-Wave Quantum Stock
AI & Quantum Computing

D-Wave Quantum: The Long Game of Two Architectures Meets a Short-Term Revenue Squeeze

June 18, 2026
Partners Group Stock
Analysis

Partners Group Races to Shore Up Confidence as Retail Redemption Storm Sinks Shares

June 18, 2026
Omv Stock
Commodities

OMV Braces for Iran Oil Flood as Dividend Appeal Holds at 8.2%

June 17, 2026
Next Post
Microsoft's $80 Billion Stress Test: When AI Capex Meets Earnings Reality

Microsoft's $80 Billion Stress Test: When AI Capex Meets Earnings Reality

Münchener Rück Stock

Munich Re Faces a Twin Agenda: A New CEO’s M&A Push and a Looming Cyber Threat

KNDS Stock

KNDS Races to Reshape Itself: From Factory Floors to Frankfurt’s Trading Floor

Recommended

Procore Technologies Stock

Procore Technologies Insider Sale: A Strategic Move or Cause for Concern?

9 months ago
ASML Stock

ASML Faces Investor Lawsuits Following Sharp Share Decline

7 months ago
Expedia Stock

Expedia Shares Navigate Growth and Investor Concentration Risks

6 months ago
Chart Industries Stock

Chart Industries Shares Navigate Uncertainty Amid Acquisition Talks and Mixed Results

9 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Outlook Therapeutics Nears FDA Verdict on July 29 After Record Rally and Steep Correction

Heidelberg Druck Locks In €436M Credit Until 2030, Betting on Defense to Offset Core Woes

Applied Materials’ SENZ Platform Pushes Stock to Record as Smart Glasses Race Heats Up

Orbital Ambitions Meet Earthbound Reality at Planet Ventures

Fiserv Grapples with Dual Turmoil as New CEO Steps In Amidst Debt Restructuring

Dell’s AI Rally Meets a Capital Strategy: Dividend, Bond, and a Microsoft Win

Trending

Analysis

XPeng Faces Twin Pressures as Shareholder Vote Looms and Subsidies Fall Flat

by Jackson Burston
June 18, 2026
0

The clock is ticking in two directions for XPeng. The electric-vehicle maker’s stock is hovering just a...

Tesla Stock

Musk Cements Control Over Tesla With 19.9% Stake as Cybertruck Arrives and Argentina Energy Deal Beckons

June 18, 2026
Renegade Gold Stock

Renegade Gold Sends Crews Into the Field for First Systematic Probe of Red Lake’s Confederation Belt

June 18, 2026
Outlook Therapeutics Stock

Outlook Therapeutics Nears FDA Verdict on July 29 After Record Rally and Steep Correction

June 18, 2026
Heidelberger Druckmaschinen Stock

Heidelberg Druck Locks In €436M Credit Until 2030, Betting on Defense to Offset Core Woes

June 18, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • XPeng Faces Twin Pressures as Shareholder Vote Looms and Subsidies Fall Flat
  • Musk Cements Control Over Tesla With 19.9% Stake as Cybertruck Arrives and Argentina Energy Deal Beckons
  • Renegade Gold Sends Crews Into the Field for First Systematic Probe of Red Lake’s Confederation Belt

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com